AAAAAA

   
Results: 1-10 |
Results: 10
CHANGES IN BODY-COMPOSITION DURING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
Authors: ASLANI A SMITH RC ALLEN BJ LEVI JA
Citation: A. Aslani et al., CHANGES IN BODY-COMPOSITION DURING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER, Applied radiation and isotopes, 49(5-6), 1998, pp. 637-638
MANAGEMENT OF GERM-CELL CARCINOMA - STATE-OF-THE-ART
Authors: LEVI JA
Citation: Ja. Levi, MANAGEMENT OF GERM-CELL CARCINOMA - STATE-OF-THE-ART, Australian and New Zealand Journal of Medicine, 28(3), 1998, pp. 391-393
INTERNATIONAL GERM-CELL CONSENSUS CLASSIFICATION - A PROGNOSTIC FACTOR-ERASED STAGING SYSTEM FOR METASTATIC GERM-CELL CANCERS
Authors: MEAD GM STENNING SP COOK P FOSSA SD HORWICH A KAYE SB OLIVER RTD DEMULDER PHM DEWIT R STOTER G SYLVESTER RJ BAJORIN DF BOSL GJ MAZUMDAR M NICHOLS CR AMATO R PIZZOCARO G DROZ JP KRAMAR A DAUGAARD G CORTESFUNES H PAZARES L LEVI JA COLLS BM HARVEY VJ COPPIN C
Citation: Gm. Mead et al., INTERNATIONAL GERM-CELL CONSENSUS CLASSIFICATION - A PROGNOSTIC FACTOR-ERASED STAGING SYSTEM FOR METASTATIC GERM-CELL CANCERS, Journal of clinical oncology, 15(2), 1997, pp. 594-603
AUSTRALIAN MULTICENTER PHASE-II TRIAL OF PACLITAXEL IN WOMEN WITH METASTATIC BREAST-CANCER AND PRIOR CHEMOTHERAPY
Authors: MICHAEL M BISHOP JF LEVI JA BELL DR ZALCBERG JR FRIEDLANDER ML OLVER IN SMITH JG TONER GC
Citation: M. Michael et al., AUSTRALIAN MULTICENTER PHASE-II TRIAL OF PACLITAXEL IN WOMEN WITH METASTATIC BREAST-CANCER AND PRIOR CHEMOTHERAPY, Medical journal of Australia, 166(10), 1997, pp. 520-523
FATAL PULMONARY TOXICITY RESULTING FROM TREATMENT WITH GEMCITABINE
Authors: PAVLAKIS N BELL DR MILLWARD MJ LEVI JA
Citation: N. Pavlakis et al., FATAL PULMONARY TOXICITY RESULTING FROM TREATMENT WITH GEMCITABINE, Cancer, 80(2), 1997, pp. 286-291
LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF COMBINED CHEMORADIOTHERAPY INDUCTION TREATMENT, WITH AND WITHOUT MAINTENANCE CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL CARCINOMA OF THE LUNG
Authors: BEITH JM CLARKE SJ WOODS RL BELL DR LEVI JA
Citation: Jm. Beith et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF COMBINED CHEMORADIOTHERAPY INDUCTION TREATMENT, WITH AND WITHOUT MAINTENANCE CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL CARCINOMA OF THE LUNG, European journal of cancer, 32A(3), 1996, pp. 438-443
PHASE-II TRIAL OF A 3-HOUR INFUSION OF PACLITAXEL IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: MILLWARD MJ BISHOP JF FRIEDLANDER M LEVI JA GOLDSTEIN D OLVER IN SMITH JG TONER GC RISCHIN D BELL DR
Citation: Mj. Millward et al., PHASE-II TRIAL OF A 3-HOUR INFUSION OF PACLITAXEL IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(1), 1996, pp. 142-148
PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: LEVI JA BEITH JM SNYDER RD TATTERSALL MH BELL D WHEELER H
Citation: Ja. Levi et al., PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED BREAST-CANCER, Australian and New Zealand Journal of Medicine, 25(5), 1995, pp. 474-478
BONE PRESENTATION OF NON-HODGKINS-LYMPHOMA - EXPERIENCE AT THE ROYAL-NORTH-SHORE-HOSPITAL, SYDNEY - HIGHLIGHTING PRIMARY BONE LYMPHOMA
Authors: SHANNON JA BELL DR LEVI JA WHEELER HR BOYLE FM
Citation: Ja. Shannon et al., BONE PRESENTATION OF NON-HODGKINS-LYMPHOMA - EXPERIENCE AT THE ROYAL-NORTH-SHORE-HOSPITAL, SYDNEY - HIGHLIGHTING PRIMARY BONE LYMPHOMA, Australian and New Zealand Journal of Medicine, 24(6), 1994, pp. 701-704
THE IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS GERM-CELL CARCINOMA
Authors: LEVI JA RAGHAVAN D HARVEY V THOMPSON D SANDEMAN T GILL G STUARTHARRIS R SNYDER R BYRNE M KERESTES Z MARGRIE S
Citation: Ja. Levi et al., THE IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS GERM-CELL CARCINOMA, Journal of clinical oncology, 11(7), 1993, pp. 1300-1305
Risultati: 1-10 |